Literature DB >> 12218132

MHC allele-specific molecular features determine peptide/HLA-A2 conformations that are recognized by HLA-A2-restricted T cell receptors.

Zichun Wang1, Richard Turner, Brian M Baker, William E Biddison.   

Abstract

The structures of alphabeta TCRs bound to complexes of class I MHC molecules and peptide show that the TCRs make multiple contacts with the alpha1 and alpha2 helixes of the MHC. Previously we have shown that the A6 TCR in complex with the HLA-A2/Tax peptide has 15 contact sites on HLA-A2. Single amino acid mutagenesis of these contact sites demonstrated that mutation of only three amino acids clustered on the alpha1 helix (R65, K66, A69) disrupted recognition by the A6 TCR. In the present study we have asked whether TCRs that recognize four other peptides presented by HLA-A2 interact with the MHC in identical, similar, or different patterns as the A6 TCR. Mutants K66A and Q155A had the highest frequency of negative effects on lysis. A subset of peptide-specific CTL also selectively recognized mutants K66A or Q155A in the absence of exogenous cognate peptides, indicating that these mutations affected the presentation of endogenous peptide/HLA-A2 complexes. These findings suggest that most HLA-A2-restricted TCRs recognize surfaces on the HLA-A2/peptide complex that are dependent upon the side chains of K66 and Q155 in the central portion of the peptide binding groove. Crystallographic structures of several peptide/HLA-A2 structures have shown that the side chains of these critical amino acids that make contact with the A6 TCR also contact the bound peptide. Collectively, our results indicate that the generalized effects of changes at these critical amino acids are probably due to the fact that they can be directly contacted by TCRs as well as influence the binding and presentation of the bound peptides.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12218132     DOI: 10.4049/jimmunol.169.6.3146

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Structures of native and affinity-enhanced WT1 epitopes bound to HLA-A*0201: implications for WT1-based cancer therapeutics.

Authors:  Oleg Y Borbulevych; Priscilla Do; Brian M Baker
Journal:  Mol Immunol       Date:  2010-07-08       Impact factor: 4.407

2.  Single MHC mutation eliminates enthalpy associated with T cell receptor binding.

Authors:  Peter J Miller; Yael Pazy; Brian Conti; David Riddle; Ettore Appella; Edward J Collins
Journal:  J Mol Biol       Date:  2007-07-26       Impact factor: 5.469

3.  Increased immunogenicity of an anchor-modified tumor-associated antigen is due to the enhanced stability of the peptide/MHC complex: implications for vaccine design.

Authors:  Oleg Y Borbulevych; Tiffany K Baxter; Zhiya Yu; Nicholas P Restifo; Brian M Baker
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

Review 4.  Conformational changes and flexibility in T-cell receptor recognition of peptide-MHC complexes.

Authors:  Kathryn M Armstrong; Kurt H Piepenbrink; Brian M Baker
Journal:  Biochem J       Date:  2008-10-15       Impact factor: 3.857

Review 5.  An alternative to current thinking about positive selection, negative selection and activation of T cells.

Authors:  Melvin Cohn
Journal:  Immunology       Date:  2004-04       Impact factor: 7.397

6.  The structure of cytomegalovirus immune modulator UL141 highlights structural Ig-fold versatility for receptor binding.

Authors:  Ivana Nemčovičová; Dirk M Zajonc
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2014-02-22

7.  Human major histocompatibility complex (MHC) class I molecules with disulfide traps secure disease-related antigenic peptides and exclude competitor peptides.

Authors:  Steven M Truscott; Xiaoli Wang; Lonnie Lybarger; William E Biddison; Cortez McBerry; John M Martinko; Janet M Connolly; Gerald P Linette; Daved H Fremont; Ted H Hansen; Beatriz M Carreno
Journal:  J Biol Chem       Date:  2008-01-14       Impact factor: 5.157

8.  Charge-based interactions through peptide position 4 drive diversity of antigen presentation by human leukocyte antigen class I molecules.

Authors:  Kyle R Jackson; Dinler A Antunes; Amjad H Talukder; Ariana R Maleki; Kano Amagai; Avery Salmon; Arjun S Katailiha; Yulun Chiu; Romanos Fasoulis; Maurício Menegatti Rigo; Jayvee R Abella; Brenda D Melendez; Fenge Li; Yimo Sun; Heather M Sonnemann; Vladislav Belousov; Felix Frenkel; Sune Justesen; Aman Makaju; Yang Liu; David Horn; Daniel Lopez-Ferrer; Andreas F Huhmer; Patrick Hwu; Jason Roszik; David Hawke; Lydia E Kavraki; Gregory Lizée
Journal:  PNAS Nexus       Date:  2022-07-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.